Resolution: S-20-22: INCLUDING BRAND NAME OF MEDICATION BESIDE GENERIC NAME IN TESTING

Forums Spring 2020 Resolution Forum Resolution: S-20-22: INCLUDING BRAND NAME OF MEDICATION BESIDE GENERIC NAME IN TESTING

  • This topic has 2 replies, 1 voice, and was last updated 3 years, 9 months ago by Reshma Pinnamaneni<br>AZCOM.
Viewing 2 reply threads
  • Author
    Posts
    • #3148
      Valerie Lile
      Keymaster

      1  WHEREAS, there are 20,000 medications currently approved for marketing according to the FDA and
      2  there are hundreds of medications required to learn during the first two years of didactics in medical
      3  schools 1,2; and

      4  WHEREAS, physicians refer to the brand name of a drug 98% of the time rather than the generic
      5  name 3,4; and

      6  WHEREAS, only 23% of medical charts provide the generic name of a medication 5; and

      7  WHEREAS, most states allow pharmacists to substitute for generic prescriptions regardless of what
      8  medication (generic or brand name) doctors prescribe according to generic-substitution laws 6; and

      9  WHEREAS, some prescriptions cannot be generic since the bioavailability of the branded prescription
      10  cannot be copied or changed to develop a generic, such as insulin 7,8; and

      11  WHEREAS, only generic names of drugs are given on exams, like Comprehensive Medical Licensing
      12  Examination- USA (COMLEX-USA), and brand names are not provided 9,2; and

      13  WHEREAS, to be a fully practicing osteopathic physician the COMLEX-USA is required 10; and

      14  WHEREAS, learning brand names for medications can pose a challenge in clinical years after only
      15  generics were presented in didactics and preceptors might only use brand names in clinic years 11;
      16  now, therefore, be it

      17  RESOLVED, that the Student Osteopathic Medical Association (SOMA) advocate Commission on
      18  Osteopathic College Accreditation (COCA) to encourage use of the format “generic (most common
      19  brand name) medication” in pharmacology education and testing within COM curricula, such as
      20  acetaminophen (Tylenol); and, be it further,

      21  RESOLVED, that the SOMA petition the National Board of Osteopathic Medical Examiners
      22  (NBOME) to encourage the use of the format “generic (most common brand name) medication,” such
      23  as, acetaminophen (Tylenol), or provide both generic and brand name in testing or use of
      24  pharmacology in all levels of the COMLEX-USA; and, be it further,

      25  RESOLVED, that SOMA encourages COCA to monitor this increased implementation of use of
      26  brand name always included with generic name of the drug in pharmacology education and provide
      27  assistance for increasing its prevalence within COM curricula as needed.

      References

      1. Commissioner, O. of the. (2020). Fact Sheet: FDA at a Glance. Retrieved from https://www.fda.gov/about-fda/fda-basics/fact-sheet-fda-glance
      2. Medical School Headquarters. (2019, March 27). USMLE and COMLEX Prep: Side Effects of Diabetes Medications. Retrieved from https://medicalschoolhq.net/br-8-usmle-and-comlex-prep-side-effects-of-diabetes-medications/
      3. Steinman, M. A., Chren, M.-M., & Landefeld, C. S. (2007, May). What’s in a name? Use of brand versus generic drug names in United States outpatient practice. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852907/
      4. Jj, Gagne, Choudhry, Kesselheim, Hutchins, D., Matlin, … Qaseem, A. (1970, January 1). Acetaminophen or Tylenol? A Retrospective Analysis of Medication Digital Communication Practices. Retrieved from https://link.springer.com/article/10.1007/s11606-018-4455-1
      5. Summers, A., Ruderman, C., Leung, F.-H., & Slater, M. (2017, September 22). Examining patterns in medication documentation of trade and generic names in an academic family practice training centre. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610475/
      6. Vivian, J. C. (2008, June 19). Generic-Substitution Laws. Retrieved from https://www.uspharmacist.com/article/generic-substitution-laws
      7. Brent, N. J., & Brent, N. J. (2019, September 10). Medication administration: Should you document generic or brand names? Retrieved from https://www.nurse.com/blog/2019/09/12/medication-administration-document-generic-brand-names/
      8. Prelipcean, M. S. (2019, August 14). Why Isn’t There More Affordable, Generic Insulin? Retrieved from https://www.healthline.com/diabetesmine/why-not-more-affordable-generic-insulin
      9. Guerra, T. (2016). Memorizing pharmacology: a relaxed approach. Raleigh, NC: Lulu.com.
      10. COMLEX-USA. (2020). Retrieved from https://www.nbome.org/exams-assessments/comlex-usa/
      11. Mullen, A. (2019, February 8). Memorizing Drug Trade Names. Retrieved from https://mullenmemory.com/memory-palace/memorizing-drug-trade-names

      Submitted by:

      Staci Hunter, OMS-II, Lincoln Memorial University-DeBusk College of Osteopathic Medicine-Harrogate Location
      Logan Shaver, OMS-II, Lincoln Memorial University-DeBusk College of Osteopathic Medicine-Harrogate Location
      Suzanne Abuhadba, OMS-I, Lincoln Memorial University-DeBusk College of Osteopathic Medicine-Knoxville Location
      Jessie Grevin, OMS-I, Lincoln Memorial University-DeBusk College of Osteopathic Medicine-Knoxville Location
      Haley Williams, OMS-I, Lincoln Memorial University-DeBusk College of Osteopathic Medicine-Harrogate Location

      Action Taken:
      Date:
      Effective Time Period: Ongoing

    • #3286
      Shaun Antonio<br>BCOM
      Guest

      I am concerned that there are some drugs that have multiple brand names owned by different companies. An example being for ibuprofen there is Motrin and Advil. Making use of brand names in test could be seen as physician and testing entities favoring companies. Further it can change prescription practices with increased familiarity of one brand over the other once students graduate into physicians.

    • #3323
      Reshma Pinnamaneni<br>AZCOM
      Guest

      Hello,

      My name is Reshma Pinnamaneni and I’m a rising OMS-II at AZCOM. I have a question on how you plan to tackle duplicity inherent in pharma industry. As Shaun Antonio mentioned, it isn’t uncommon to have drugs that have different brand names. Also, how do you plan on keeping the curriculum unbiased towards one brand name over another?

      Thank you,
      Reshma

Viewing 2 reply threads
  • The forum ‘Spring 2020 Resolution Forum’ is closed to new topics and replies.